Cantel Medical Q3 Earnings Rise, But Misses View - Quick Facts

(RTTNews) - Cantel Medical Corp. (CMN) Thursday reported higher profit for the third quarter, as a result of improved revenue growth. However, earnings fell short of analysts' expectations.

The company's earnings rose to $10.24 million or $0.25 per share from $9 million or $0.22 per share in the prior-year quarter. Analysts polled by Thomson Reuters expected the company to report earnings of $0.26 per share for the quarter. Analysts' estimates typically exclude special items. Quarterly sales improved to $120.05 million from $105 million last year, while analysts estimated revenues of $117.40 million. Commenting on the results, Andrew Krakauer, Cantel's President and CEO said : "Sales growth performance was led this quarter by our Medivators Endoscopy segment which had excellent year-over-year organic growth of 19%. This unit achieved record sales for the third consecutive quarter with double digit growth in all product categories."